More Press Releases

View Older Stories View Newer Stories

May 21, 2026 05:02PM Imperial Announces Voting Results for the Election of Directors
May 21, 2026 05:00PM DATA Communications Management Corp. Report of Voting Results Annual and Special Meeting of Shareholders Held on May 21, 2026
May 21, 2026 05:00PM Saturn Oil & Gas Inc. Announces Approval of All Resolutions and Voting Results of Annual and Special Shareholder Meeting
May 21, 2026 05:02PM Moleculin Highlights Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting Highlighting Cardiac Safety Data for Annamycin
May 21, 2026 05:01PM Lynozyfic® (linvoseltamab) Monotherapy Demonstrates Deep and Rapid Responses in All Treated Patients with Second-Line-Plus Systemic Amyloid Light Chain Amyloidosis
May 21, 2026 05:01PM Agendia to Present New FLEX Study Data at ASCO 2026 Supporting NCCN Clinical Practice Guidelines in Oncology Update Recognizing MammaPrint for Guiding Anthracycline Use in Early-Stage Breast Cancer
May 21, 2026 05:01PM Bristol Myers Squibb to Unveil New Data at ASCO® 2026 Demonstrating Strength and Breadth of Scientific Innovation Across Oncology Portfolio and Next-Generation Pipeline
May 21, 2026 05:01PM Akari Therapeutics Reports Breakthrough Preclinical Data Demonstrating Synergistic Activity of AKTX-101 with KRAS Inhibition in KRAS-Mutated Pancreatic Cancer Models
May 21, 2026 05:01PM Syndax Announces Four Revuforj® (revumenib) Abstracts Accepted for ASCO 2026, Including an Oral Presentation of Post-Transplant Data
May 21, 2026 05:00PM Medicure Announces AGM Results and Appointment of New Director
May 21, 2026 05:00PM Medicure Reports Financial Results for Quarter Ended March 31, 2026 and Schedules May 25, 2026 Conference Call
May 21, 2026 05:00PM IC Group Announces Q1 2026 Earnings Release Date and Investor Webinar
May 21, 2026 05:00PM AerSale Announces Participation at the 2026 Jefferies Aftermarket MRO Virtual Summit
May 21, 2026 05:00PM Boehringer Ingelheim’s oncology portfolio shows strong promise across multiple cancers at ASCO 2026
May 21, 2026 05:00PM TruGolf Reports First Quarter 2026 Results
May 21, 2026 05:00PM HiberCell to Present Preliminary Results from the Phase 1b Trial of GCN2 Activator HC-7366 when Combined with WELIREG® (belzutifan) for the Treatment of Late-Line Clear Cell Renal Cell Carcinoma (ccR
May 21, 2026 05:00PM Canadian Net REIT Announces 2026 First-Quarter Results and a Distribution Increase
May 21, 2026 05:00PM Asher Biotherapeutics Announces Two Presentations at the ASCO 2026 Annual Meeting Highlighting Clinical Progress Across Its CD8-Targeted Cytokine Pipeline
May 21, 2026 05:00PM Zodiac Partners II, LLC Provides an Update to its Previously Announced $46 million Tender Offer to Acquire Destination XL Group, Inc. for $0.82 Per Share in Cash
May 21, 2026 05:00PM NVIDIA Announces Upcoming Events for Financial Community
May 21, 2026 05:00PM Accent Therapeutics to Present Trial in Progress Poster for Phase 1/2 Study of ATX-295 at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026 05:00PM Ficerafusp Alfa Plus Pembrolizumab Demonstrated Differentiated Three-Year Overall Survival and Deep Responses Driven by TGF-β Inhibition in 1L R/M HPV-Negative HNSCC
May 21, 2026 05:00PM Olema Oncology Announces Encouraging Initial Clinical Data from the Phase 1 Study of OP-3136, a KAT6 Inhibitor, at 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting
May 21, 2026 05:00PM Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy
May 21, 2026 05:00PM WhiteFiber Signs AI Compute Agreement with Total Contract Value in Excess of $160 Million with Investment-Grade Technology Customer
May 21, 2026 05:00PM Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
May 21, 2026 05:00PM Greenberg Traurig Bolsters Government Contracts and Space Practices with Shaun Kennedy in Denver
May 21, 2026 05:00PM Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026
May 21, 2026 05:00PM New Clinical Data for Izalontamab Brengitecan and Novel ADC Pipeline to be Presented at ASCO 2026
May 21, 2026 05:00PM Navient declares second quarter common stock dividend
May 21, 2026 05:00PM Dell Technologies to Present at Investor Conference in June
May 21, 2026 05:00PM BlossomHill Therapeutics to Present Preliminary Results From Phase 1 Dose Escalation/Backfill Cohorts in Phase 1/2 SOLARA Trial of OMNI-EGFR Inhibitor, BH-30643, in Advanced EGFR-mutant NSCLC at the 2
May 21, 2026 05:00PM Obsidian Therapeutics to Present Phase 2 Clinical Data for OBX-115 in Advanced Melanoma in Oral Presentation at 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Agenus Presents Phase 2 BOT+BAL Melanoma Data Showing Durable Responses and Meaningful Survival in Advanced Checkpoint-Refractory Melanoma at ASCO 2026
May 21, 2026 05:00PM A2 Biotherapeutics Presents Safety and Efficacy Data from the EVEREST-2 Clinical Study, Including Update on the First Complete Response to CAR T-Cell Therapy in a Patient with Non-Small Cell Lung Canc
May 21, 2026 05:00PM Compass Therapeutics to Present Promising Phase 1 Clinical Data for CTX-8371 in Patients with Advanced Malignancies Treated in the Post-Checkpoint Inhibitor Setting at the 2026 ASCO Annual Meeting
May 21, 2026 05:00PM 858 Therapeutics Announces Initial Data from First-in-Human Phase 1/2 Trial of PARG Inhibitor ETX-19477 to be Presented at 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Artera Presents Multiple ASCO 2026 Abstracts on Multimodal AI (MMAI) Risk Stratification and Treatment Decisions in Cancer
May 21, 2026 05:00PM Rgenta Therapeutics Presents Positive Preliminary Data from Ongoing Phase 1a/b Clinical Trial of RGT-61159 in Patients with Adenoid Cystic Carcinoma and Colorectal Cancer at the 2026 ASCO Meeting
May 21, 2026 05:00PM New ASCO and EHA 2026 Data Demonstrate Gilead and Kite’s Momentum Across Antibody-Drug Conjugates and Cell Therapy in Oncology
May 21, 2026 05:00PM Servier Presentations at ASCO 2026 Spotlight Expanding Rare Oncology Portfolio
May 21, 2026 05:00PM Convergent Therapeutics to Present Largest Set of Prospective Phase 2 Data for an Alpha Radiopharmaceutical in Lu-PSMA-Exposed Metastatic Castration-Resistant Prostate Cancer at ASCO 2026
May 21, 2026 05:00PM Marriott International and The Fern Hotels & Resorts Celebrate 75 Signings and 50 Openings for Series by Marriott in India
May 21, 2026 05:00PM Flatiron Health Brings 25+ Research Acceptances and Next-Generation Capabilities to ASCO 2026
May 21, 2026 05:00PM Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
May 21, 2026 05:00PM Legend Biotech Announces Presentations at ASCO 2026
May 21, 2026 05:00PM Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
May 21, 2026 05:00PM Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types
May 21, 2026 05:00PM Agenus and Noetik Present ASCO 2026 Data Linking AI Analysis of Routine Pretreatment Tumor Pathology Images to Response and Survival with BOT+BAL in MSS Metastatic CRC
View Newer Stories View Older Stories